Share

From this page you can share Pay No Attention to That Clinical Data or Squandered Tax Payer Dollars for Medicaid Drugs to a social bookmarking site or email a link to the page.
Social WebE-mail
Enter multiple addresses on separate lines or separate them with commas.
(Your Name) has forwarded an article to you from CommonDreams.org: Pay No Attention to That Clinical Data or Squandered Tax Payer Dollars for Medicaid Drugs

(Your Name) forwarded this article to you from CommonDreams.org.

Sign up here if you would like to receive daily news from CommonDreams.org.

Pay No Attention to That Clinical Data or Squandered Tax Payer Dollars for Medicaid Drugs

"The American Heart Association is cautioning patients if they stop taking Vytorin abruptly, Schering-Plough and Merck's stock price will fall."

That's how a cartoon showing a news anchor would read after revelations that the American Heart Association--which receives nearly $2 million a year from Vytorin makers Merck and Schering-Plough--and the American College of Cardiology told patients to stay on the drug despite a recent damning study.